Approval · Notice of Compliance 842 · 2002
THYROGEN: Notice of Compliance 842
Issued May 31, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 842
- Date
- May 31, 2002
- Company
- Genzyme Canada Inc
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Thyroid stimulating hormone
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| THYROGEN | 02246016 | Marketed |
Medicinal ingredients
- THYROTROPHIN 0.9 MG per ML